HonorHealth Research Institute, City of Hope and TGen lead international team in creating ‘robust’ early-detection method for pancreatic cancer

SCOTTSDALE, Ariz. — Oct. 18, 2023 — In a significant breakthrough that could eventually extend the survival of patients with one of the deadliest of all malignancies, an international team of researchers have devised an investigational blood test that might one day help doctors detect pancreatic cancer earlier.Continue reading

Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program

ROOT, Switzerland–Oct 12, 2023 (BUSINESS WIRE)– Novocure (NASDAQ: NVCR) today announced it has entered into an agreement with Stanford University to establish the Stanford School of Medicine Tumor Treating Fields (TTFields) Research Program. The program is intended to support both preclinical studies and clinical trials with TTFields, electric fields that exert physical forces to kill cancer cells via a variety of mechanisms.Continue reading

UArizona Startup NeuTherapeutics Wins $2.5M Grant to Fund Clinical Trial of PhytoSERM, a Natural Approach to Menopausal Hot Flashes

TUCSON, Ariz. – NeuTherapeutics, a Tucson startup founded to commercialize University of Arizona technology has received a $2.5M Small Business Innovation Research (SBIR) grant from  the National Institutes of Health/ National Institute on Aging (NIA) to conduct a Phase 2 clinical trial to evaluate the impact of a new dietary supplement, PhytoSERM, on menopausal hot flashes in women.Continue reading

GT Medical Technologies, Inc.’ GammaTile® Therapy Awarded 2023 Most Promising New Product of the Year by The Phoenix: The Medical Device and Diagnostic Conference for Chief Executive Officers

Oct. 13, 2023 /PRNewswire/ — GT Medical Technologies, Inc. a medical device company dedicated to improving the lives of patients with brain tumors, today announced that its FDA-cleared GammaTile® Therapy was awarded the 2023 Most Promising New Product of the Year by The Phoenix: The Medical Device and Diagnostic Conference for Chief Executive Officers. Continue reading

Barrow Neurological Institute receives $16.7 million NIH award to help coordinate new national ALS research consortium

(PHOENIX – Oct. 5, 2023) –  Barrow Neurological Institute has received a large award from the National Institutes of Health (NIH) to help create and lead a groundbreaking and transformative national amyotrophic lateral sclerosis (ALS) clinical research consortium. The award is the largest Barrow has ever received from the NIH with a first year budget of $16.7 million.Continue reading